Inventiv Health buy Riccardo
Start price
26.01.08
/
50%
€22.11
Target price
26.07.08
€24.00
Performance (%)
-28.09%
End price
26.07.08
€15.90
Summary
This prediction ended on 26.07.08 with a price of €15.90. The prediction for Inventiv Health disappointed with a performance of -28.09%. Riccardo has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Inventiv Health | - | - | - | - |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% | 68.786% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% | 100.066% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% | 43.024% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% | 63.222% |
Comments by Riccardo for this prediction
In the thread Inventiv Health diskutieren
InVentiv Health
inVentiv Health Inc. reported third-quarter adjusted operating income of $31.7 million, or 49 cents a share, topping the mean estimate of analysts polled by Thomson Financial of 44 cents a share. Revenue for the three months ended Sept. 30 rose 29% to $254.9 million, above Wall Street's $249.4 million estimate. A year earlier, the Somerset, N.J.-based provider of value-added services to the pharmaceuticals and life sciences industries posted revenue of $197.8 million.
(Laufzeit überschritten)